Skip to content

Photodynamic Therapy (PDT) vs Chemopeeling for the treatment of multiple actinic keratoses on the underarms

Photodynamic Therapy (PDT) vs Chemopeeling for the treatment of multiple actinic keratoses on the underarms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-004258-26-AT
Enrollment
26
Registered
2005-05-19
Start date
2005-06-23
Completion date
Unknown
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic Keratosis

Interventions

Product Name: Trichloroacetic acid Pharmaceutical Form: Cutaneous liquid INN or Proposed INN: Trichloroacetic Acid CAS Number: 76-03-9 Other descriptive name: TCA Concentration unit: % percent Concen

Sponsors

University Clinic of Dermatology Division of Special and Enviromental Dermatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients (at leat 50 years old) with multiple actinic keratoses on both underarms(at least 3/side) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: -Immunsuppression -Reduced general health condition -Reduced renal function -Intolerance against aminolevulinic acid/ trichloroacetic acid (TCA) -Systemic administration of retinoids within the last 6 months -Current adminsitration of Vitamin-K antagonists

Design outcomes

Primary

MeasureTime frame
Main Objective: A comparison of two different therapeutic modalities (phototdynamic therapy with aminolevulinic acid vs. chemopeeling with trichloroacetic acid) in the treatment of multiple actinic keratoses on the underarms to determine the optimal treatment of this precancerous cuatanous condition of high prevalence. ;Secondary Objective: Side effects, tolerability the two therapies by the patients, cosmetical results of the two treatments;Primary end point(s): Primary endpoint is the count of healed actinic keratotic lesions after 52 weeks after treatment with each of the two therapies.

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026